Related Experiment Videos

[Sinus arrest after intravenous administration of lidocaine]

Schweizerische Medizinische Wochenschrift
|December 22, 1979
PubMed

Insights

Lidocaine infusion can cause sinus standstill and bradycardia in patients with coronary artery disease. Atropine effectively restored sinus rhythm and improved blood pressure in a patient experiencing this adverse event.

Area of Science:

  • Cardiology
  • Clinical Pharmacology

Background:

  • Coronary artery disease (CAD) and prior myocardial infarction (MI) are significant risk factors for cardiac arrhythmias.
  • Antiarrhythmic drug therapy, such as lidocaine, is commonly used in managing cardiac conditions but can have adverse effects.

Observation:

  • A 60-year-old patient with a history of CAD and MI developed sinus standstill with severe bradycardia (41/min) during a lidocaine infusion.
  • Concomitant severe hypotension (70/50 mm Hg) was noted during the episode.
  • The patient was receiving lidocaine at a rate of 2 mg/min for antiarrhythmic treatment.

Findings:

  • Withdrawal of the lidocaine infusion and administration of intravenous atropine (0.5 mg) rapidly restored sinus rhythm within 4 minutes.
  • A gradual increase in blood pressure was observed over the subsequent 45 minutes.
  • The patient recovered without evidence of a new myocardial infarction or lasting harm.

Implications:

  • This case highlights a potential adverse effect of lidocaine, specifically sinus standstill and bradycardia, in patients with underlying cardiac disease.
  • Prompt recognition and management with atropine can effectively reverse these life-threatening complications.
  • Careful monitoring of patients on antiarrhythmic infusions is crucial, especially those with significant coronary artery disease.

Related Concept Videos